original articlesurogenital tumorsA prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel
urogenital tumors
Under a Creative Commons license
open access
Key words
castration-resistant prostate cancer
abiraterone acetate
prognostic
risk
survival
Cited by (0)
Copyright © 2016 THE AUTHORS. Published by Elsevier Ltd.